Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQ1OJ4
|
|||
| Drug Name |
VIR-2218
|
|||
| Synonyms |
ALN-HBV02
Click to Show/Hide
|
|||
| Drug Type |
Small interfering RNA
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [1] | |
| Company |
Alnylam Pharmaceuticals; Vir Biotechnology
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus Large envelope protein (HBV S) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Vir Biotechnology. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.